消費者直接遺伝子検査市場規模および予測（2020年 - 2030年）、世界および地域シェア、動向、成長機会分析レポートカバレッジ：検査タイプ別（ニュートリゲノミクス検査、予測検査、キャリア検査、その他）、技術別（全ゲノムシークエンシング、一塩基多型チップ、ターゲット分析、その他）、流通チャネル別（オンライン、オフライン）、地域別（北米、欧州、アジア太平洋、中東＆アフリカ、中南米）

Direct-to-Consumer Genetic Testing Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Test Type (Nutrigenomics Testing, Predictive Testing, Carrier Testing, and Others), Technology (Whole Genome Sequencing, Single Nucleotide Polymorphism Chips, Targeted Analysis, and Others), Distribution Channel (Online and Offline), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

消費者直接遺伝子検査市場規模は、2022年に17億1,500万米ドル、2030年には71億9,100万米ドルに達すると推定され、2022年から2030年までの年平均成長率は19.6%を記録すると予測されている。消費者直接遺伝子検... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
The Insight Partners ザ・インサイトパートナーズ	2023年10月4日	US$4,550 シングルユーザライセンスライセンス・価格情報注文方法はこちら	162	英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

消費者直接遺伝子検査市場規模は、2022年に17億1,500万米ドル、2030年には71億9,100万米ドルに達すると推定され、2022年から2030年までの年平均成長率は19.6%を記録すると予測されている。

消費者直接遺伝子検査市場成長の主な推進要因としては、遺伝性疾患の罹患率の増加と遺伝子検査の潜在的利益に関する意識の高まりが市場を牽引している。一方、消費者直接遺伝子検査に関連する高コストとプライバシーの懸念が市場成長の妨げとなっている。

遺伝子検査の潜在的利益に関する意識の高まり

消費者はますます自己好奇心とエンパワーメントに駆り立てられており、それは遺伝子検査とフォローアップ・カウンセリングを提供するサービスに対する意識の高まりに反映されている。遺伝子検査に対する認識と受容は、世界中の人々の間で着実に高まっている。受動的な顧客から力を与えられ自覚的な顧客へのシフトが遺伝子検査市場を牽引している。消費者直接遺伝子検査（DTC-GT）が本来持っているアクセスのしやすさは大きな利点であり、消費者は自分の遺伝子情報に自由にアクセスし、個人に合わせた見識や推奨を得ることができる。多くの業界では、個人のニーズを特定し、それに応えるためにお金を払う意欲が高まり、オーダーメイドの製品や体験を求める顧客が大幅に増加している。

遺伝学的検査は、不必要な検査やスクリーニング検査の必要性を排除し、予防、治療、状態のモニタリングのための利用可能な最良の選択肢を患者に指し示すことによって、糖尿病やある種のがんなど、様々な疾病の負担増に対処する上で重要な役割を果たしている。医学のあらゆる分野における遺伝子検査の役割は、急速に増大している。遺伝子検査はすでに診断を迅速化し、回復力の高い疾患に対する遺伝的素因を持つ人々を特定するのに役立っている。妊娠前検査や出生前遺伝学的検査は、遺伝性疾患の保因者であることを知らせることによって、生殖に関する決定を行う潜在的な患者を支援する。

様々な疾患に関連する幅広い表現型における遺伝的変異の重要性に対する認識の高まりは、市場の成長をさらに促進すると予想される。これらの検査は、その人が特定の疾患や懸念される表現型に対する遺伝的素因を有しているかどうかを明らかにし、可能な限り早期に診断して疾患の治療を開始することができる。ヒトゲノムが初めて解読され、ゲノム解読技術が開発されたことで、ゲノム研究が急成長している。これはまた、消費者直接遺伝子検査が新たなサービスとなることにもつながっている。世界的な消費者直接遺伝子検査市場は、これらの検査が様々な健康リスク、個人の特徴、全体的な幸福に関する有効な情報を提供することから、多くの人々に影響を与えている。さらに、臨床検査技師のDTC-GTへの急速な移行も市場を牽引する重要な要因である。例えば、MITテクノロジー・レビューによると、2019年に米国でDNA検査を受けた人は約8％、約2,600万人に上る。この数は今後数年間で1億人以上に増加すると予想されている。

このように、遺伝子検査に関する国民の意識の高まりが、消費者直接遺伝子検査市場を牽引している。

消費者直接遺伝子検査市場：セグメント別概要

消費者直接遺伝子検査市場は、検査タイプ、技術、流通チャネルで分析される。検査タイプ別では、祖先検査、ニュートリゲノミクス検査、予測検査、キャリア検査、その他に区分される。2022年には家系検査分野が最大の市場シェアを占め、予測検査分野は2022-2030年に高いCAGRを記録すると予測されている。

技術に基づく市場は、全ゲノムシーケンス、一塩基多型チップ、標的分析、その他に区分される。一塩基多型チップセグメントは、2022年に大きな市場シェアを占め、2022-2030年に高いCAGRを記録すると予測されている。

流通チャネルに基づき、消費者直接遺伝子検査市場はオンラインとオフラインに分類される。2022年には、オンラインセグメントが最大の市場シェアを占め、2022-2030年に最も高いCAGRを記録すると予測されている。

消費者直接遺伝子検査市場地理的概観

地域別に見ると、消費者直接遺伝子検査市場は北米、欧州、アジア太平洋、中東・アフリカ、中南米で分析されている。地域別では、遺伝性疾患の有病率の増加、研究開発への高額支出、米国食品医薬品局（FDA）による製品承認、技術の進歩により、北米が大きな市場シェアを占めている。ヘルスケアビジネス部門の成長と消費者直接遺伝子検査の利用増加は、予測期間中、同地域の市場に成長機会を提供し続けるだろう。さらに、遺伝性疾患に対する懸念の高まりに対処するための政府からの支援の高まりは、北米の消費者直接遺伝子検査市場の進展に有利である。北米の消費者直接遺伝子検査市場では、米国が最大の市場シェアを占めている。FDAは2022年に23andMeの遺伝性前立腺がんマーカーに関するDTC遺伝子検査を承認した。消費者直接遺伝子検査は米国で大きな人気を集めている。米国国立衛生研究所（NIH）によると、DTC遺伝子検査はテレビ、印刷広告、インターネットを通じて消費者に直接販売される。このように、遺伝性疾患の有病率の増加と、慢性疾患を治療するための先進的な遺伝子治療の採用が増加していることが、米国市場を牽引している。

さらに、アジア太平洋地域は予測期間中に最も速い成長率を目撃すると予想されている。アジア太平洋地域における消費者直接遺伝子検査市場の普及は、優れた治療ソリューションに対するニーズの高まり、遺伝性疾患の早期スクリーニングに対する意識の高まり、研究開発活動への注力の高まりに起因している。さらに、ゲノミクスのための研究開発の急増、多くの患者プール、医療インフラのアップグレードは、予測期間中、アジア太平洋地域における消費者直接遺伝子検査市場の成長に有利に働くと予測されている。

さらに、欧州は世界の消費者直接遺伝子検査市場で2番目に大きな市場シェアを占めている。この地域市場は、遺伝子検査に関する意識の高まりと遺伝性疾患および癌の有病率の上昇により、今後数年間で大きく成長すると予想される。欧州の消費者直接遺伝子検査市場では、ドイツが最大の市場シェアを占めており、予測期間中は英国が最も速い成長が見込まれている。

過去数年間における技術の進歩の高まりは、消費者直接遺伝子検査市場の拡大に多くの機会をもたらしている。ニッチな治療領域向けにカスタマイズされた検査キットの開発と慢性疾患の有病率の上昇が、ドイツの消費者直接遺伝子検査市場に利益をもたらしている。

消費者直接遺伝子検査市場主要プレイヤー

消費者直接遺伝子検査市場の調査では、Genesis Healthcare Co、Ancestry Genomics Inc、Color Health Inc、Helix Inc、Myriad Genetics, Inc、Living DNA Ltd、23andMe Inc、Genetic Technologies Ltd、Gene By Gene Ltd、Full Genomes Corp Incなどの主要企業が分析された。

消費者直接遺伝子検査市場に関する報告書を作成する際に参照した主な一次情報源および二次情報源には、世界保健機関（WHO）、FDA（食品医薬品局）、英国遺伝子検査ネットワーク、フランス国立衛生局、国立衛生研究所などがある。

ページTOPに戻る

TABLE OF CONTENTS

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Direct-To-Consumer Genetic Testing Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Global PEST Analysis
5. Direct-To-Consumer Genetic Testing Market - Key Industry Dynamics
5.1 Market Drivers
5.1.1 Growing Incidence of Genetic Disorders
5.1.2 Increasing Awareness About Potential Benefits of Genetic Testing
5.2 Market Restraints
5.2.1 High Cost and Privacy Concerns Associated With Direct-to-Consumer Genetic Testing
5.3 Market Opportunities
5.3.1 Growing Adoption of Single Nucleotide Polymorphism (SNP) Chips
5.4 Future Trends
5.4.1 Growing Interest in Pharmacogenetics and Increasing Adoption of Telehealth
5.5 Impact Analysis
6. Direct-To-Consumer Genetic Testing Market - Global Market Analysis
6.1 Direct-To-Consumer Genetic Testing Market Revenue (US$ Mn), 2022 – 2030
7. Global Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 – by Test Type
7.1 Overview
7.2 Direct-To-Consumer Genetic Testing Market Revenue Share, by Test Type 2022 & 2030 (%)
7.3 Ancestry Testing
7.3.1 Overview
7.3.2 Ancestry Testing: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Nutrigenomics Testing
7.4.1 Overview
7.4.2 Nutrigenomics Testing: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Predictive Testing
7.5.1 Overview
7.5.2 Predictive Testing: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Carrier Testing
7.6.1 Overview
7.6.2 Carrier Testing: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
8. Global Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 – by Technology
8.1 Overview
8.2 Direct-To-Consumer Genetic Testing Market Revenue Share, by Technology 2022 & 2030 (%)
8.3 Whole Genome Sequencing
8.3.1 Overview
8.3.2 Whole Genome Sequencing: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Single Nucleotide Polymorphism Chips
8.4.1 Overview
8.4.2 Single Nucleotide Polymorphism Chips: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Targeted Analysis
8.5.1 Overview
8.5.2 Targeted Analysis: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
9. Global Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 – by Distribution Channel
9.1 Overview
9.2 Direct-To-Consumer Genetic Testing Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
9.3 Online Platform
9.3.1 Overview
9.3.2 Online Platform: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Offline Platform
9.4.1 Overview
9.4.2 Offline Platform: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10. Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 – Geographic Analysis
10.1 North America: Direct-To-Consumer Genetic Testing Market
10.1.1 Overview
10.1.2 North America: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.1 North America: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.1.2.2 North America: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.1.2.3 North America: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.1.3 North America: Direct-To-Consumer Genetic Testing Market, by Country, 2022 & 2030 (%)
10.1.3.1 US: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.1.3.2 US: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.1.3.2.1 US: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.1.3.2.2 US: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.1.3.2.3 US: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.1.3.3 Canada: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.1.3.4 Canada: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.1.3.4.1 Canada: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.1.3.4.2 Canada: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.1.3.4.3 Canada: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.1.3.5 Mexico: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.1.3.6 Mexico: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.1.3.6.1 Mexico: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.1.3.6.2 Mexico: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.1.3.6.3 Mexico: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2 Europe: Direct-To-Consumer Genetic Testing Market
10.2.1 Overview
10.2.2 Europe: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.2.2.1 Europe: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.2.2.2 Europe: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.2.2.3 Europe: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.3 Europe: Direct-To-Consumer Genetic Testing Market, by Country, 2022 & 2030 (%)
10.2.3.1 Germany: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.2.3.2 Germany: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.2.1 Germany: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.2.3.2.2 Germany: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.2.3.2.3 Germany: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.3.3 UK: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.2.3.4 UK: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.4.1 UK: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.2.3.4.2 UK: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.2.3.4.3 UK: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.3.5 France: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.2.3.6 France: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.6.1 France: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.2.3.6.2 France: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.2.3.6.3 France: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.3.7 Italy: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.2.3.8 Italy: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.8.1 Italy: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.2.3.8.2 Italy: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.2.3.8.3 Italy: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.3.9 Spain: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.2.3.10 Spain: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.10.1 Spain: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.2.3.10.2 Spain: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.2.3.10.3 Spain: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.3.11 Rest of Europe: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.2.3.12 Rest of Europe: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.12.1 Rest of Europe: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.2.3.12.2 Rest of Europe: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.2.3.12.3 Rest of Europe: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3 Asia Pacific: Direct-To-Consumer Genetic Testing Market
10.3.1 Overview
10.3.2 Asia Pacific: Direct-To-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
10.3.2.1 Asia Pacific: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.3.2.2 Asia Pacific: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.3.2.3 Asia Pacific: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.3 Asia Pacific: Direct-To-Consumer Genetic Testing Market, by Country, 2022 & 2030 (%)
10.3.3.1 China: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.3.3.2 China: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.2.1 China: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.3.3.2.2 China: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.3.3.2.3 China: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.3.3 Japan: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.3.3.4 Japan: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.4.1 Japan: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.3.3.4.2 Japan: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.3.3.4.3 Japan: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.3.5 India: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.3.3.6 India: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.6.1 India: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.3.3.6.2 India: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.3.3.6.3 India: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.3.7 Australia: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.3.3.8 Australia: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.8.1 Australia: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.3.3.8.2 Australia: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.3.3.8.3 Australia: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.3.9 South Korea: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.3.3.10 South Korea: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.10.1 South Korea: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.3.3.10.2 South Korea: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.3.3.10.3 South Korea: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.3.11 Rest of Asia Pacific: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.3.3.12 Rest of Asia Pacific: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.12.1 Rest of Asia Pacific: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.3.3.12.2 Rest of Asia Pacific: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.3.3.12.3 Rest of Asia Pacific: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.4 Middle East & Africa Direct-To-Consumer Genetic Testing Market
10.4.1 Overview
10.4.2 Middle East & Africa: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.4.2.1 Middle East & Africa: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.4.2.2 Middle East & Africa: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.4.2.3 Middle East & Africa: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.4.3 Middle East & Africa: Direct-To-Consumer Genetic Testing Market, by Country, 2022 & 2030 (%)
10.4.3.1 Saudi Arabia: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.4.3.2 Saudi Arabia: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.4.3.2.1 Saudi Arabia: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.4.3.2.2 Saudi Arabia: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.4.3.2.3 Saudi Arabia: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.4.3.3 South Africa: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.4.3.4 South Africa: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.4.3.4.1 South Africa: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.4.3.4.2 South Africa: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.4.3.4.3 South Africa: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.4.3.5 UAE: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.4.3.6 UAE: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.4.3.6.1 UAE: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.4.3.6.2 UAE: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.4.3.6.3 UAE: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.4.3.7 Rest of Middle East & Africa: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.4.3.8 Rest of Middle East & Africa: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.4.3.8.1 Rest of Middle East & Africa: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.4.3.8.2 Rest of Middle East & Africa: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.4.3.8.3 Rest of Middle East & Africa: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.5 South & Central America: Direct-To-Consumer Genetic Testing Market
10.5.1 Overview
10.5.2 South & Central America: Direct-To-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
10.5.2.1 South & Central America: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.5.2.2 South & Central America: Direct-To-Consumer Genetic Testing Market, By Technology, 2020–2030 (US$ Million)
10.5.2.3 South & Central America: Direct-To-Consumer Genetic Testing Market, By Distribution Channel, 2020–2030 (US$ Million)
10.5.3 South & Central America: Direct-To-Consumer Genetic Testing Market Share by Country – 2022 & 2030, (%)
10.5.3.1 Brazil: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.5.3.2 Brazil: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.5.3.2.1 Brazil: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.5.3.2.2 Brazil: Direct-To-Consumer Genetic Testing Market, By Technology, 2020–2030 (US$ Million)
10.5.3.2.3 Brazil: Direct-To-Consumer Genetic Testing Market, By Distribution Channel, 2020–2030 (US$ Million)
10.5.3.3 Argentina: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.5.3.4 Argentina: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.5.3.4.1 Argentina: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.5.3.4.2 Argentina: Direct-To-Consumer Genetic Testing Market, By Technology, 2020–2030 (US$ Million)
10.5.3.4.3 Argentina: Direct-To-Consumer Genetic Testing Market, By Distribution Channel, 2020–2030 (US$ Million)
10.5.3.5 Rest of South & Central America: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.5.3.6 Rest of South & Central America: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.5.3.6.1 Rest of South & Central America: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.5.3.6.2 Rest of South & Central America: Direct-To-Consumer Genetic Testing Market, By Technology, 2020–2030 (US$ Million)
10.5.3.6.3 Rest of South & Central America: Direct-To-Consumer Genetic Testing Market, By Distribution Channel, 2020–2030 (US$ Million)
11. Direct-To-Consumer Genetic Testing Market–Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 Genesis Healthcare Co
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Ancestry Genomics Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Color Health Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Helix Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Myriad Genetics, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Living DNA Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7andMe Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Genetic Technologies Ltd
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Gene By Gene Ltd
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Full Genomes Corp Inc
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms

ページTOPに戻る

Table of Contents

Summary

The direct-to-consumer genetic testing market size is estimated to reach US$ 1.715 billion in 2022 to US$ 7.191 billion by 2030; the market is projected to record a CAGR of 19.6% from 2022 to 2030.

Some of the key driving factors for the direct-to-consumer genetic testing market growth are the growing incidence of genetic disorders and increasing awareness about the potential benefits of genetic testing drive the market. Whereas the high cost and privacy concerns associated with direct-to-consumer genetic testing hamper market growth.

Increasing Awareness About Potential Benefits of Genetic Testing

Consumers are increasingly driven by self-curiosity and empowerment, reflected by increased awareness of services that offer genetic testing and follow-up counseling. Awareness and acceptance of genetic testing are steadily increasing among the population worldwide. The shift from passive to empowered and self-aware customers is driving the genetic testing market. The inherent accessibility of direct-to-consumer genetic testing (DTC-GT) is a major advantage, giving consumers free access to their genetic information and personalized insights and recommendations. Many industries are seeing a significant increase in customers seeking tailored products and experiences, with an increased willingness to pay to identify and meet individual needs.

Genetic testing plays an important role in addressing the increasing burden of various diseases, such as diabetes and certain cancers, by eliminating the need for unnecessary examinations and screening tests and pointing the person to the best available options for prevention, treatment, and monitoring of the condition. The role of genetic testing in all areas of medicine is rapidly increasing. Genetic testing is already speeding up diagnoses, and it aids in identifying people with a genetic predisposition to highly resilient diseases. Preconception and prenatal genetic testing assist potential patients with reproductive decisions by informing them of their carrier status for genetic disorders.

The increasing awareness of the importance of genetic variations across a wide range of phenotypes associated with different diseases is further expected to promote market growth. These tests reveal whether a person has a genetic predisposition to a particular disease or phenotype of concern, which can be diagnosed as early as possible to initiate the disease treatment. The first sequencing of the human genome and developmets in genome sequencing technology is enabling rapid growth in genomics research. This has also led to direct-to-consumer genetic testing becoming a new service. The global direct-to-consumer genetic testing market has influenced many people as these tests provide valid information about various health risks, personal characteristics, and overall well-being. Further, the rapid transition of the clinical laboratory workforce to DTC-GT is another crucial factor driving the market. For example, according to MIT Technology Review, approximately 8%, or nearly 26 million, people in the US took DNA tests in 2019. That number is expected to rise to over 100 million in the coming years.

Thus, the growing awareness among the population regarding genetic testing drives the direct-to-consumer genetic testing market.

Direct-to-Consumer Genetic Testing Market: Segmental Overview

The direct-to-consumer genetic testing market is analyzed on the test type, technology, and distribution channel. The market, by test type, is segmented into ancestry testing, nutrigenomics testing, predictive testing, carrier testing, and others. The ancestry testing segment held the largest market share in 2022, whereas the predictive testing segment is anticipated to register a higher CAGR during 2022–2030.

The market based on technology is segmented into whole genome sequencing, single nucleotide polymorphism chips, targeted analysis, and others. The single nucleotide polymorphism chips segment held a larger market share in 2022 and is estimated to register a higher CAGR during 2022–2030.

Based on the distribution channel, the direct-to-consumer genetic testing market is categorized into online and offline. In 2022, the online segment held the largest market share and is anticipated to register the highest CAGR during 2022–2030.

Direct-to-Consumer Genetic Testing Market: Geographical Overview

Based on geography, the direct-to-consumer genetic testing market is analyzed for North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. Based on regions, North America accounts for a significant market share owing to the growing prevalence of genetic diseases, high spending on research and development, product approvals by the US Food and Drug Administration (FDA), and technological advances. The growing healthcare business sector and the increase in use of direct-to-consumer genetic testing will continue to offer growth opportunities for market in the region during the forecast period. Further, the rising support from government to address growing concerns about genetic diseases favors North America's direct-to-consumer genetic testing market progress. US held the largest market share in the North America direct-to-consumer genetic testing market. The FDA approved 23andMe's DTC genetic test in 2022 for a hereditary prostate cancer marker. Direct-to-consumer genetic testing has been gaining significant popularity in the US. According to the US National Institutes of Health (NIH), DTC genetic tests are marketed directly to consumers via television, print advertising, or the Internet. Thus, the increasing prevalence of genetic disorders, coupled with the rising adoption of advanced gene therapies to treat chronic diseases, drives the market in the US.

Moreover, Asia Pacific region is expected to witness fastest growth rate during the forecast period. The proliferation of the direct-to-consumer genetic testing market in Asia Pacific is attributed to the increasing need for superior treatment solutions, a rise in awareness of the early screening of genetic disorders, and the growing focus on research and development activities. Additionally, an upsurge in the R&D for genomics, a large pool of patients, and upgrades in healthcare infrastructure are projected to favor the growth of the direct-to-consumer genetic testing market in Asia Pacific during the forecast period.

Moreover, Europe held the second largest market share in the global direct-to-consumer genetic testing market. The regional market is expected to grow significantly in the coming years owing to the rising awareness regarding genetic tests and the rising prevalence of genetic disorders and cancer. Germany held the largest market share in the European direct-to-consumer genetic testing market, whereas the UK is expected to witness the fastest growth during the forecast period.

The rising technological advancements in the past few years have opened numerous opportunities for the direct-to-consumer genetic testing market expansion. The development of customized testing kits for niche therapeutic areas and the rising prevalence of chronic diseases benefit the direct-to-consumer genetic testing market in Germany.

Direct-to-Consumer Genetic Testing Market: Key Players

Under the direct-to-consumer genetic testing market study, a few key players were analyzed, which include Genesis Healthcare Co, Ancestry Genomics Inc, Color Health Inc, Helix Inc, Myriad Genetics, Inc, Living DNA Ltd, 23andMe Inc, Genetic Technologies Ltd, Gene By Gene Ltd, and Full Genomes Corp Inc.

A few of the key primary and secondary sources referred to while preparing the report on the direct-to-consumer genetic testing market are the World Health Organization (WHO), FDA (Food and Drug Administration), UK Genetic Testing Network, and French National Authority for Health, and National Institutes of Health

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療）の最新刊レポート

The Insight Partners社のバイオテクノロジー分野での最新刊レポート

本レポートと同じKEY WORD（genetic）の最新刊レポート

よくあるご質問

The Insight Partners社はどのような調査会社ですか?

The Insight Partnersはインドに本社を置く調査会社です。経験豊富な専門家チームを通じて、お客様に最適な調査と分析を提供することに専念しています。幅広い分野をカバーしていますがヘルスケ... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療）の最新刊レポート

The Insight Partners社のバイオテクノロジー分野での最新刊レポート

本レポートと同じKEY WORD（genetic）の最新刊レポート

よくあるご質問

The Insight Partners社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?